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Nephrocalcinosis, acute calcium oxalate (CaOx) nephropathy, and renal stone disease can lead to inflamma-
tion and subsequent renal failure, but the underlying pathological mechanisms remain elusive. Other crystal-
lopathies, such as gout, atherosclerosis, and asbestosis, trigger inflammation and tissue remodeling by induc-
ing IL-1β secretion, leading us to hypothesize that CaOx crystals may induce inflammation in a similar manner. 
In mice, intrarenal CaOx deposition induced tubular damage, cytokine expression, neutrophil recruitment, 
and renal failure. We found that CaOx crystals activated murine renal DCs to secrete IL-1β through a pathway 
that included NLRP3, ASC, and caspase-1. Despite a similar amount of crystal deposits, intrarenal inflamma-
tion, tubular damage, and renal dysfunction were abrogated in mice deficient in MyD88; NLRP3, ASC, and 
caspase-1; IL-1R; or IL-18. Nephropathy was attenuated by DC depletion, ATP depletion, or therapeutic IL-1 
antagonism. These data demonstrated that CaOx crystals trigger IL-1β–dependent innate immunity via the 
NLRP3/ASC/caspase-1 axis in intrarenal mononuclear phagocytes and directly damage tubular cells, leading 
to the release of the NLRP3 agonist ATP. Furthermore, these results suggest that IL-1β blockade may prevent 
renal damage in nephrocalcinosis.
Introduction
Kidney stone disease affects about 12% of men and 5% of women 
during their lifetimes in the United States (1). Unlike symptomatic 
urolithiasis, intrarenal nephrocalcinosis is often asymptomatic, but 
can lead to significant kidney injury and renal failure (1–3). Cal-
cium oxalate (CaOx) stones account for the vast majority of calculi 
in primary and secondary forms of hyperoxaluria (4, 5). In addition, 
acute oxalosis (e.g., in ethylene glycol poisoning) can induce acute 
kidney injury as a result of widespread intrarenal CaOx deposi-
tion (6). Histopathology of human CaOx nephropathy as well as 
microarray analysis of rodent CaOx nephropathy document a sub-
stantial contribution of interstitial inflammation to tissue remod-
eling, but the molecular and cellular mechanisms of CaOx-induced 
renal inflammation remain largely unknown (7–11).
Inflammation and tissue remodeling in various crystallopathies, 
such as gout (caused by monosodium urate crystals), pseudogout 
(caused by calcium pyrophosphate crystals; ref. 12); atheroscle-
rosis (caused by cholesterol crystals; ref. 13) silicosis (caused by 
silica crystals; ref. 14) and asbestosis (caused by asbestos; ref. 14), 
involve a unique intracellular signaling pathway for the secretion 
of the proinflammatory cytokine IL-1β: the NLRP3 inflamma-
some/apoptosis-associated speck-like protein containing CARD/
caspase-1 (NLRP3/ASC/caspase-1) axis (15). The NLRP3 inflam-
masome is a large cytoplasmatic protein complex able to integrate 
multiple extracellular and intracellular danger signals into ASC 
binding and activation of caspase-1 (also known as pro–IL-1β con-
verting enzyme; ref. 15). In contrast to other NF-κB–dependent 
cytokines that are readily secreted, the inactive pro-form of IL-1β 
requires cleavage (e.g., by caspase-1) as an additional enzymatic step 
before the bioactive form of IL-1β can be secreted from the cell (15).
Here, we hypothesized that CaOx crystals have a similar agonis-
tic potential on NLRP3 and trigger IL-1β secretion and that this 
process contributes to CaOx-induced tissue inflammation, for 
example, in nephrocalcinosis and/or CaOx nephropathy.
Results
CaOx crystals need NLRP3/ASC/caspase-1 to induce IL-1β in DCs. We 
hypothesized that CaOx crystals have the same potential to acti-
vate DCs as do crystals of uric acid, calcium pyrophosphate, or 
cholesterol (12, 13). CaOx crystals were of small size when used 
in vitro together with bone marrow–derived DCs (BMDCs; Sup-
plemental Figure 1; supplemental material available online with 
this article; doi:10.1172/JCI63679DS1). CaOx crystal exposure 
activated murine BMDCs to release IL-1β in a dose-dependent 
manner, but only when cells were prestimulated with LPS, TNF, 
IL-1α, or histones (Figure 1A and Supplemental Figure 2). West-
ern blotting of DC supernatants revealed that LPS prestimulation 
was a prerequisite for induction of pro–IL-1β expression (Figure 
1A). LPS also induced pro–caspase-1 in BMDCs, and CaOx crys-
tals induced caspase-1 activation similar to that by the NLRP3 
agonist ATP (Figure 1A). To address a potential NLRP3 agonistic 
effect of CaOx crystals, BMDCs from Nlrp3–/–, Asc–/–, and Casp1–/– 
mice were also prepared; LPS/CaOx crystals were unable to induce 
IL-1β secretion in these cells (Figure 1, B and C). Although LPS 
induced pro–IL-1β and pro–caspase-1 expression, CaOX crystals 
Conflict of interest: The authors have declared that no conflict of interest exists.
Citation for this article: J Clin Invest. 2013;123(1):236–246. doi:10.1172/JCI63679.
Downloaded on October 19, 2013.   The Journal of Clinical Investigation.   More information at  www.jci.org/articles/view/63679
research article
 The Journal of Clinical Investigation   http://www.jci.org   Volume 123   Number 1   January 2013 237
were unable to induce caspase-1 activation in Nlrp3–/–, Asc–/–, and 
Casp1–/– BMDCs, as was the case with LPS/ATP stimulation (Fig-
ure 1, B and C). Additionally, the caspase inhibitor Z-VAD-FMK 
had the same effect on LPS/CaOx crystal–induced IL-1β secretion 
in BMDCs (Figure 1D). Thus, CaOx crystals induced IL-1β secre-
tion in DCs via the NLRP3/ASC/caspase-1 axis.
CaOx crystal–induced NLRP3 activation depends on phagocytosis and 
potassium efflux. Whether agonists directly interact with NLRP3 
remains unknown, but various mechanisms are involved in NLRP3 
activation by extracellular danger signals: particle uptake into 
the cell by phagocytosis, lysosomal cathepsin leakage, potassium 
efflux from the cell, P2X7 channel activation, and intracellular oxi-
dative stress (15). We therefore performed a series of experiments 
to determine which of the aforementioned factors contributes 
to CaOx crystal–induced NLRP3 activation. Cytochalasin D, a 
phagocytosis-blocking agent that inhibited actin polymerization 
and crystal uptake into intracellular endosomes (Figure 2A), sig-
nificantly reduced LPS/CaOx crystal–induced IL-1β secretion in 
BMDCs, whereas the cathepsin inhibitor CA074Me and the anti-
oxidant N-acetyl cysteine had no effect (Figure 2B). Furthermore, 
blocking potassium efflux by a high concentration of potassium in 
the extracellular fluid had the same effect (Figure 2C), which sug-
gests that potassium efflux is required for CaOx-induced NLRP3 
activation. Comparison of LPS/CaOx crystal–induced IL-1β secre-
tion between WT and P2x7–/– BMDCs did not support a contri-
bution of P2X7 in this context (Figure 2D). Thus, CaOx crystals 
induced NLRP3-mediated IL-1β secretion in DCs via phagocytic 
uptake of CaOx crystals into intracellular endosomes as well as 
via inducing potassium efflux from the cell, a process known to 
activate NLRP3 (16).
CaOx crystals induce IL-1β secretion in renal DCs, but not in renal 
parenchymal cells. To determine whether CaOx crystals have a simi-
lar potential to activate renal DCs or renal parenchymal cells, we 
stimulated primary renal CD45+CD11c+ DCs, ECs, mesangial cells 
(MCs), and tubular epithelial cells (TECs) with LPS/CaOx crystals 
as above. LPS/CaOx crystals induced IL-1β secretion in renal DCs 
in a manner similar to that of LPS/ATP, whereas none of the renal 
parenchymal cell types responded to the stimulation (Figure 2E). 
Western blotting confirmed this finding and also showed that LPS 
stimulation only induced pro–IL-1β expression in renal DCs (Fig-
ure 2F). Hence, CaOx crystals induced secretion of mature IL-1β 
only in renal DCs, not in renal parenchymal cells.
CaOx crystals induce ATP release from dying TECs. Consistent with 
previous reports (10), CaOx crystal exposure killed TECs (as 
demonstrated by lactate dehydrogenase [LDH] release) in a dose-
dependent manner, independent of Nlrp3 genotype (Supplemen-
tal Figure 3). Dying cells release intracellular damage-associated 
molecular pattern molecules (DAMPs) that have the potential to 
activate pattern recognition receptors of other cells (17). ATP is 
one such intracellular DAMP, reported to drive sterile inflamma-
Figure 1
CaOx crystals activate DCs to secrete 
mature IL-1β. (A) WT BMDCs were stimu-
lated with increasing doses of CaOx crystals 
with or without LPS prestimulation (1 μg/ml), 
and IL-1β secretion was measured by ELISA. 
ATP served as a positive control of NLRP3 
activation. Western blotting of supernatants 
showed induction of pro–IL-1β by LPS; only 
CaOx crystals and ATP induced mature IL-1β 
secretion. This process involved caspase-1 
activation (cleavage product, 10 kDa). (B) 
DCs from WT, Nlrp3–/–, and Asc–/– mice. 
CaOx crystal– and ATP-induced IL-1β secre-
tion depended on the presence of NLRP3 
and ASC regardless of pro–IL-1β induction. 
(C) Similar results were obtained in DCs 
isolated from Casp1–/– mice. (D) WT BMDCs 
were stimulated with LPS/CaOx with or with-
out the caspase inhibitor Z-VAD-FMK. Data 
are means ± SD from 3 separate experi-
ments. *P < 0.05 vs. medium; ***P < 0.001 
vs. respective WT (B and C) or PBS (D).
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Figure 2
Mechanisms of CaOx crystal–induced IL-1β secretion. (A) BMDCs were primed with LPS (1 μg/ml) and stimulated with CaOx crystals in the pres-
ence or absence of cytochalasin D. TEM showed that CaOx crystals appeared outside the cell (asterisks) and inside intracellular endosomes 
(arrowheads), whereas cytochalasin D treatment inhibited their uptake in DCs. (B) Incubation with cytochalasin D, CA074Me, and N-acetyl cysteine 
(NAC) affected IL-1β secretion, measured by ELISA in cell culture supernatants after 6 hours. (C) Similar experiments were performed using 75 mM 
KCl in cell culture medium to block potassium efflux from the DCs. NaCl of an identical molarity was used as a molarity control. High extracellular 
potassium prevented CaOx-induced IL-1β secretion. (D) DCs were isolated from WT and P2x7–/– mice. ATP-induced, but not CaOx-induced, IL-1β 
secretion depended on the presence of P2X7. Data are means ± SD from 3 independent experiments. (E) Renal ECs, MCs, TECs, and renal DCs 
were primed with LPS and exposed to CaOx crystals, and IL-1β secretion was measured. ATP was used as a positive control for NLRP3 activa-
tion. (F) Western blotting. LPS priming induced pro–IL-1β expression only in DCs. (G) Primary TECs were isolated from WT mice and cultured with 
increasing concentrations of CaOx. ATP release was quantified in cell culture supernatant upon 18 hours of CaOx crystal exposure with and without 
increasing concentrations of apyrase. (H) Coculture of LPS-primed DCs with CaOx (100 μg/ml) damaged TECs with or without apyrase (1 U/ml). 
IL-1β secretion was measured by ELISA after 24 hours. Data are means ± SD from 3 independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001 
vs. medium (B, C, and E); vs. WT (D); vs. 1,000 μg/ml CaOx alone (G); or as indicated by brackets.
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tion upon cell death via activation of NLRP3 (18, 19). Thus, we 
tested whether CaOx crystal–induced death of cultured TECs is 
associated with marked ATP release. In fact, CaOx crystal expo-
sure induced ATP concentrations in cell culture supernatants in 
a dose-dependent manner (Figure 2G). In addition, extracellular 
ATP levels were readily degraded by adding apyrase at concentra-
tions of 0.25 U/ml or higher (Figure 2G). Accordingly, coculture 
of BMDCs with CaOx-damaged primary tubular cells — with or 
without apyrase treatment — significantly reduced their capacity 
to secrete IL-1β (Figure 2H). Thus, CaOx crystals activated and 
destabilized TECs, a process that promoted the release of ATP, 
which activated DCs to release IL-1β.
Oxalate nephropathy involves diffuse crystal deposition, renal inflam-
mation, and failure. Given the potential of CaOx crystals to activate 
renal DCs via NLRP3/ASC/caspase-1 in both direct and indirect 
ways, we suspected they make a functional contribution to oxa-
late nephropathy. Direct DC activation would require CaOx crys-
tals to also reach the renal interstitial compartment, where DCs 
and other antigen-presenting cells span a dense network around 
the tubules (20). Murine oxalate nephropathy was characterized 
by diffuse CaOx crystal deposition throughout the kidney, with 
focal crystal casts obstructing proximal and distal tubules within 
the outer medulla as well as within the cortex, which was absent 
in control mice (Figure 3A and Supplemental Figure 4). Single 
crystals or small clumps of crystals, similar in appearance to the 
ones we applied for cell culture (Supplemental Figure 1), not only 
adhered to the luminal membranes of TECs, but were also found 
intracellularly within endosomes (Figure 3, B and C, and Supple-
mental Figure 5A). Diffuse CaOx crystal deposits were also found 
in the renal interstitial compartment, in close proximity to and 
within renal interstitial cells (Figure 3, B and D, and Supplemental 
Figure 5B). In fact, transmission EM (TEM) imaging showed that 
interstitial cells occasionally engulfed and took up crystals (Figure 
3D). Renal CaOx crystal deposition was associated with diffuse 
neutrophil infiltrates and tubular necrosis mainly at the inner 
stripe of the outer medulla, as demonstrated by the disintegration 
of TECs and granular casts in tubular lumen (Figure 4, A and B). 
The structural alterations of oxalate nephropathy were associated 
with renal failure, as shown by a transient increase in plasma creati-
nine and BUN levels, peaking at 24 hours, compared with those in 
vehicle-injected mice (Figure 4A and Supplemental Figure 6). Intra-
renal mRNA expression of the kidney injury markers KIM-1 and 
L-FABP, as well as that of the proinflammatory cytokines IL-6 and 
TNF-α, was increased (Figure 4C). Together, these observations 
indicated that murine oxalate nephropathy was characterized by 
diffuse CaOx crystal formation inside the tubular and the intersti-
tial compartments, which is associated with tubular injury, renal 
inflammation, and failure.
Oxalate nephropathy depends on MyD88, IL-1R, and IL-18. Cytokine 
expression and neutrophil infiltration are suggestive of the 
involvement of innate immunity in oxalate nephropathy. To test 
this concept, we induced oxalate nephropathy in Myd88–/– mice, 
since MyD88 is a central signaling adaptor that translates innate 
pattern recognition into NF-κB activation and expression of pro-
inflammatory cytokines, including pro–IL-1β and pro–IL-18 (21, 
22). Unlike WT mice, Myd88–/– mice were almost entirely protected 
from acute kidney injury and failure, despite harboring identical 
CaOx crystal depositions (Figure 5). Il1r–/– mice were almost entire-
ly protected, whereas Il18–/– mice displayed only partial protection 
(Figure 5). Thus, oxalate nephropathy depended on MyD88-medi-
ated innate immunity, which also involved IL-1R and IL-18.
Oxalate nephropathy is abrogated in Nlrp3–/–, Asc–/–, and Casp1–/– mice. 
To test the functional contribution of the NLRP3/ASC/caspase-1 
axis, we induced oxalate nephropathy in Nlrp3–/–, Asc–/–, or Casp1–/– 
Figure 3
CaOx nephropathy in C57BL/6 mice. (A) Kidney sections showed CaOx 
crystals distributed throughout, especially in the tubular lumina (Pizzo-
lato stain; left) or viewed under polarized light (right). Original magnifica-
tion, ×100 (left); ×200 (right); ×400 (inset). (B) At higher magnification, 
Pizzolato stain showed smaller (granular) crystals inside TECs as well 
as in the renal interstitial compartment. Original magnification, ×400 
(left), ×1,000 (right). (C) TEM (left) confirmed large CaOx crystal aggre-
gates within the tubular lumen (black arrow) as well as in the interstitial 
space (white arrow). Freeze-fracture EM (right) identified CaOx crystals 
in the tubular lumen (black arrow) as well as inside cytoplasmic organ-
elles, some of which appeared to be lysosomes (white arrows). Original 
magnification, ×3,000. (D) TEM also showed CaOx crystals within the 
interstitial compartment in close proximity to interstitial cells (left; black 
arrows). At higher magnification (right), an interstitial cell (white asterisk 
indicates nucleus) engulfed a CaOx crystal (black arrows denote outer 
cell membrane); neighboring TECs are denoted by black asterisks. 
Original magnification, ×7,000 (left); ×25,000 (right).
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mice. Despite renal CaOx deposits identical to those of WT con-
trols, all 3 groups were partially protected from kidney injury and 
failure, as evidenced by significant reductions in plasma creati-
nine, BUN, tubular damage, mRNA expression of tubular injury 
markers KIM-1 and L-FABP, and interstitial neutrophil infiltrates 
(Figure 6 and Supplemental Figure 7). Hence, NLRP3, ASC, and 
caspase-1 contributed to renal inflammation, damage, and dys-
function in CaOx nephropathy.
CaOx crystal–induced acute kidney injury depends on intrarenal 
mononuclear phagocytes. The results of our in vitro studies sug-
gested that CaOx crystal–induced IL-1β secretion may selec-
tively originate from the intrarenal network of mononuclear 
phagocytes, such as DCs and macrophages. Flow cytometry of 
renal cell suspension obtained after 24 hours of CaOx exposure 
revealed activation of CD45+CD11c+ intrarenal myeloid DCs, as 
evidenced by increased surface expression of CD40 and CD86 
as well as by protrusions and dendrite expansion, visualized by 
scanning EM (Figure 7, A and B, and Supplemental Figure 8A). 
Next, we depleted monocytic phagocytes from the kidney by 
2 injections of clodronate liposomes before inducing oxalate 
nephropathy. Depletion of CD11c+ cells was confirmed by flow 
cytometry of renal cell suspensions (Supplemental Figure 8B). 
This procedure reduced intrarenal IL-1β production, as deter-
mined by ELISA from kidney homogenates (Supplemental Fig-
ure 8C). This was associated with partial protection from acute 
kidney injury compared with control liposome–treat-
ed mice (despite identical amounts of CaOx depos-
its), as documented by a significant reduction of 
plasma creatinine level, BUN level, and tubular dam-
age (Figure 7C). Similar results were obtained when 
cells were selectively depleted by diphtheria toxin in 
CD11c DTRg mice (Figure 7D and Supplemental 
Figure 8, B and C). Thus, intrarenal mononuclear 
phagocytes mediated cytokine signaling and subse-
quent renal inflammation, injury, and failure in oxa-
late nephropathy.
Degradation of extracellular ATP with apyrase protects 
mice from oxalate nephropathy. Our in vitro studies 
showed that dying TECs released ATP, an endogenous 
NLRP3 agonist that triggers IL-1β secretion in DCs 
(19). Apyrase injection degrades extracellular ATP and 
can block the NLRP3-agonistic effect of this endog-
enous danger signal during sterile inflammation (18). 
We therefore used apyrase injections to test whether 
extracellular ATP also contributes to renal inflamma-
tion and injury during oxalate nephropathy. A single 
intraperitoneal injection of 20 U apyrase partially reduced tubu-
lar injury and neutrophil recruitment during oxalate nephropa-
thy and improved renal excretory function, as documented by a 
significant reduction of plasma creatinine and BUN levels com-
pared with vehicle-treated control mice (Figure 8A). Systemic 
IL-6 and MCP-1 levels were also reduced (Supplemental Figure 
9A). We concluded that extracellular ATP (e.g., as it is released 
from dying TECs) served as an additional trigger for renal 
inflammation and dysfunction in oxalate nephropathy.
The recombinant IL-1R antagonist anakinra prevents oxalate 
nephropathy. All of the above observations suggested a func-
tional role of NLRP3/ASC/caspase-1–mediated IL-1β secretion 
as a previously unrecognized pathomechanism for inflamma-
tion and tissue damage in CaOx nephropathy. Thus, therapeutic 
blockade of IL-1β may be able to interfere with this pathomecha-
nism and protect against renal failure. Anakinra, a recombinant 
version of the endogenous IL-1 receptor antagonist, is approved 
by the FDA for the treatment of rheumatoid arthritis (23, 24). 
Intraperitoneal injection of anakinra dose-dependently reduced 
tubular injury and neutrophil recruitment and improved renal 
excretory function during oxalate nephropathy (Figure 8B and 
Supplemental Figure 9B). We concluded that IL-1β mediated 
inflammation and tissue damage in kidney injury induced by 
CaOx crystals, and thus IL-1 blockade protected from renal fail-
ure in oxalate nephropathy.
Figure 4
Oxalate nephropathy in C57BL/6 mice. (A) Oxalate feed-
ing caused diffuse oxalate deposition within 24 hours and 
significantly increased plasma creatinine levels and BUN 
levels. (B) PAS staining illustrated tubular necrosis, which 
was quantified by semiquantitative scoring (loss of brush 
border, flattening of cells, disruption and detachment of 
tubular cells from basement membranes). Renal neutro-
phil counts were determined by Ly6G B1.2 immunostaining 
and quantified per 15 hpfs. Original magnification, ×100. 
(C) Renal mRNA expression was determined by real-time 
RT-PCR. Data are means ± SEM from 5–6 mice per group. 
*P < 0.05, ***P < 0.001.
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Discussion
Renal stone disease is widely considered to be a mechanical prob-
lem causing intra- or extrarenal urinary outflow obstruction, but 
crystal nephropathies are also associated with significant intrare-
nal inflammation that can cause acute kidney injury (3, 11). We 
hypothesized that the NLRP3 inflammasome — an intracellular 
pattern recognition platform that translates danger signaling into 
secretion of mature IL-1β — is involved in this process, because 
immune recognition of numerous crystals involves the NLRP3/
ASC/caspase-1 axis (12–14).
In contrast to widely expressed Toll-like receptors or Rig-like 
helicases, the NLRP3/ASC/caspase-1 axis is restricted to antigen-
presenting cells inside the kidney (25–27). We used clodronate 
liposome in WT mice or diphtheria toxin in CD11c DTRg mice 
to demonstrate that CaOx-induced intrarenal IL-1β secretion 
originated from the intrarenal network of interstitial mononuclear 
phagocytes, which includes several DC populations (28). CaOx crys-
tals also formed in the interstitial compartment, where they were 
internalized by interstitial cells, a process demonstrated by us and 
others using TEM (present study and ref. 11). Our in vitro studies 
confirmed that phagocytic uptake was required for CaOx-induced 
IL-1β secretion in DCs, an observation consistent with the mode 
of NLRP3 activation by monosodium urate and calcium pyrophos-
phate crystals (12), silica (14), asbestos (14), and cholesterol crys-
tals (13) in other disease contexts. Potassium efflux from the cell, 
occurring upon cell membrane disruption or pore formation by 
bacterial toxins, is another trigger of NLRP3 activation in DCs (15, 
29). CaOx crystal–induced NLRP3 activation also depended on this 
mechanism, which was again consistent with previous reports on 
crystals of asbestos, monosodium urate (14), silica (30), cholesterol 
(31), and calcium phosphate (32). Intrarenal DCs and macrophages 
are important regulators of innate immunity and tissue remodeling 
in the kidney (28, 33). They express all known pattern recognition 
platforms that translate infectious and noninfectious dangers into 
local expression of proinflammatory cytokines and chemokines, 
causing subsequent immune-mediated pathology in the kidney (28, 
33, 34). In addition, renal DCs express numerous negative regula-
tors of innate immunity that limit overshooting renal inflamma-
tion and inappropriate kidney injury, e.g., in postischemic tubular 
necrosis (35–37). The present study is the first to our knowledge to 
demonstrate that acute kidney injury in crystal nephropathy largely 
depends on the capacity of intrarenal mononuclear phagocytes to 
trigger renal inflammation upon crystal recognition.
TEM and freeze-fracture EM demonstrated crystal uptake into 
intracellular compartments of TECs in vivo. TECs express NLRP3 
but lack pro–IL-1β induction upon NF-κB priming (26, 38, 39). 
Therefore, CaOx crystals did not trigger mature IL-1β secretion in 
TECs. However, TECs internalize CaOx crystals, inducing oxidative 
stress and tubular cell necrosis (40–42). We confirmed this find-
ing and showed that necrotic tubular cells released ATP, a potent 
NLRP3 agonist (19). Iyer et al. recently demonstrated that ATP is 
released upon acute tubular necrosis, which triggers NLRP3 activa-
tion and renal inflammation, a process that aggravates postisch-
emic acute kidney injury (43). These results were supported by our 
present in vitro studies. In addition, the protective effects of apyrase 
treatment on CaOx nephropathy supported the functional contri-
bution of ATP to renal inflammation and damage. It is notewor-
thy that apyrase injections also reduced plasma levels of IL-6 and 
MCP-1, implicating some systemic effects, which could be either 
causative or secondary for the improvement of the renal phenotype.
Figure 5
Role of MyD88, IL-1R, and IL-18 in CaOx nephropathy. (A) Oxalate deposition was similar in Myd88–/–, Il1r–/–, and Il18–/– mice, but plasma 
creatinine levels and BUN were not significantly increased, suggesting a protective role of these molecules in CaOX-induced renal dam-
age. (B) PAS staining illustrated tubular necrosis. Original magnification, ×100. (C) Tubular injury score was determined by semiquantitative 
scoring, and renal neutrophil counts were determined by immunostaining and quantified per hpf. Data are means ± SEM from 5–6 mice per 
group. *P < 0.05, **P < 0.01, ***P < 0.001.
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IL-1 blockade with appropriate antagonists is an established 
treatment of IL-1–dependent diseases, such as rheumatoid 
arthritis, Still’s disease, and rare hereditary autoinflammatory 
disorders (24). Recently, IL-1 blockade also proved effective in 
crystal-mediated diseases, such as gout and pseudogout (44, 45). 
The dramatic therapeutic effects seem to directly relate to the 
fact that NLRP3 translates crystal recognition into IL-1β secre-
tion as a central element of crystal-induced tissue inflammation 
and pathology (24). Our data demonstrated a similar therapeutic 
effect of the recombinant IL-1 receptor antagonist anakinra in 
CaOx nephropathy in mice, which suggests that IL-1 blockade 
may also reduce renal inflammation and kidney damage in other 
crystal nephropathies.
In conclusion, CaOx crystals triggered IL-1β–dependent innate 
immunity via the NLRP3/ASC/caspase-1 axis in DCs. Thus, intra-
renal antigen-presenting cells promoted IL-1–dependent inflam-
mation and kidney injury in renal stone disease. In addition, CaOx 
crystals indirectly activated NLRP3 by damaging TECs and releas-
ing the NLRP3 agonist ATP. IL-1β blockade with anakinra pre-
vented CaOx kidney injury disease, which could be a novel thera-
peutic approach to limit kidney damage in crystal nephropathies.
Methods
Animal studies
C57BL/6, NOD/ShiLt, NOD/Casp1–/–, Il1r1–/–, Il18–/–, and Myd88–/– mice 
were procured from Jackson Laboratories. Nlrp3–/– and Asc–/– mice were 
provided by J. Tschopp (University of Lausanne, Lausanne, Switzerland) 
and by V. Dixit (Genentech, San Francisco, California, USA). CD11c 
DTRg mice were provided by C. Kurts (University of Bonn, Bonn, Ger-
many) and D. Engel (University of Bonn, Bonn, Germany). Mice were 
housed in groups of 5 in filter top cages with unlimited access to food 
and water. Cages, food, and water were sterilized by autoclaving before 
use. 6- to 8-week-old mice received a single intraperitoneal injection of 
100 mg/kg sodium oxalate and 3% sodium oxalate in drinking water, 
and kidneys were harvested after 24 hours. DC depletion was achieved 
by 2 intravenous injections of liposomal clodronate (200 μl) at 48 and 24 
hours before injection of sodium oxalate. Control liposomes were used 
as vehicle control. In another experiment, CD11c DTRg mice were given 
a single intravenous injection of 8 ng diphtheria toxin (Sigma-Aldrich) 6 
hours before sacrifice. Urine samples were collected after 24 hours, before 
sacrifice by cervical dislocation and harvest of plasma and kidney tissue 
(46). Kidneys were kept at –80°C for protein isolation and in RNA later 
solution at –20°C for RNA isolation. One part of the kidney was also kept 
in formalin to be embedded in paraffin for histological analysis. 
Assessment of renal injury
Kidney sections (2 μm) were stained with periodic acid–Schiff (PAS) 
reagent. Tubular injury was scored by assessing the percentage of necrotic 
tubules and presence of tubular casts. Ly6B.2+ neutrophils were identi-
fied by immunostaining (clone 7/4; Serotec). Pizzolato staining visualized 
CaOx crystals, and crystal deposit formation in the kidney was evaluated 
as described previously (47), using the following point values: 0, no depos-
its; 1, crystals in papillary tip; 2, crystals in cortical medullary junction; 3, 
crystals in cortex. When crystals were observed in multiple areas, points 
were combined. Plasma creatinine and BUN were measured using Urea FS 
kit (DiaSys Diagnostic Systems) according to the manufacturer’s proto-
col. Both parameters were corrected for body weight. Neutrophil infiltrates 
were counted in 15 high-power fields (hpfs) per section.
EM
Scanning EM. Kidney tissues were rinsed with PBS and postfixed with 1% 
aqueous osmium tetroxide for a total of 2.5 hours. Subsequently, tissues 
were rinsed and dehydrated through a graded series of ethanol to abso-
Figure 6
Role of NLRP3, ASC, and caspase-1 in CaOx nephropathy. (A) Nlrp3–/–, Asc–/–, and Casp1–/– mice showed CaOx deposits similar to those of WT 
mice, but decreased creatinine levels. (B) PAS staining illustrated reduced tubular necrosis compared with WT. Original magnification, ×100. (C) 
Tubular injury score and white cell counts were also reduced compared with WT. Data are means ± SEM from 5–6 mice per group. *P < 0.05, 
**P < 0.01, ***P < 0.001.
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sion values were normalized using 18s RNA as a housekeeping gene. All 
primers used for amplification were from Metabion. The expression of 
KIM-1, IL-6, and TNF-α was analyzed using the following primers: Kim-1 
forward, TCAGCTCGGGAATGCACA; Kim-1 reverse, TGGTTGCCTTC-
CGTGTCT; L-FABP forward, AGGCAATAGGTCTGCCCGAGGAC; 
L-FABP reverse, CCAGTTCGCACTCCTCCCCCA; IL-6 forward, TGAT-
GCACTTGCAGAAAACA; IL-6 reverse, ACCAGAGGAAATTTTCAATAG-
GC; TNF-α forward, CCACCACGCTCTTCTGTCTAC; TNF-α reverse, 
AGGGTCTGGGCCATAGAACT.
Flow cytometry
Anti-mouse CD11c, CD40, CD86, and CD45 antibodies (BD Biosci-
ences — Pharmingen) were used to detect activated DC and leukocyte 
populations in kidneys. F4/80, 7/4, and Ly6G antibodies (Abd Serotec) 
and CD3, NK1.1, CD11b, and CD103 antibodies (BD Biosciences — 
Pharmingen) were used to detect macrophage, neutrophil, T cell, natural 
killer cell, and mononuclear phagocyte populations in kidneys. Respec-
tive isotype antibodies were used to demonstrate specific staining of cell 
populations. Quantification of cell number was achieved using count-
ing beads for FACS (Invitrogen).
Cell culture studies
BMDCs were established as described previously (50). Renal DCs were 
isolated from whole kidneys by magnetic bead separation (MACS) 
using CD11c MicroBeads (Miltenyi Biotech). The purity of CD11c+ 
renal cells was confirmed by FACS analysis using anti-CD11c anti-
body (BD Biosciences — Pharmingen). Cells were stimulated for 3 
hours with 1 μg/ml LPS followed by 100 μg/ml CaOx crystals or 
stimulated with 5 mM ATP for 6 hours (all Sigma-Aldrich). Cell-free 
supernatants were analyzed for cytokine secretion by ELISA (BD Bio-
sciences — Pharmingen) and immunoblot analysis. Primary TECs were 
lute ethanol and critical-point dried using liquid CO2. After mounting 
on stubs, the specimens were sputter-coated with a gold-palladium alloy 
for 1.5 minutes. DCs in suspension were rinsed in PBS and centrifuged to 
concentrate the cells. Then cells were dropped on coated coverslips and 
allowed to adhere; coverslips were fixed as above. Coverslips were cut into 
pieces prior to mounting on stubs. Images were viewed with a Hitachi 2600 
electron microscope.
TEM. Kidneys were immersed in cold modified Karnovsky fixative con-
taining 3% glutaraldehyde and 1% paraformaldehyde in sodium cacodylate 
buffer (pH 7.4) processed as previously described (48). In another set of 
experiments, BMDCs were stimulated with 1 μg/ml LPS and 100 μg/ml 
CaOx, with or without cytochalasin D pretreatment. After stimulation, 
cells were fixed with 2% paraformaldehyde with 2% glutaraldehyde in PBS 
buffer (pH 7.4) and processed. The samples were viewed with a JEOL model 
1200EX electron microscope.
Quick-freeze deep-etch EM. 1.5-mm bread slices of nonfixed kidney or kid-
ney sections fixed overnight in 2% glutaraldehyde in NaHCa (100 mM 
NaCl, 30 mM Hepes, and 2 mM CaCl2, pH 7.2) were used after rinsing in 
NaHCa. Tissues were then cooled to 4°K with liquid helium; mounted in 
a Balzers 400 vacuum evaporator, fractured, and etched for 2.5 minutes at 
–104°C; rotary replicated with approximately 3 nm platinum, as previously 
described (49); and viewed using a JEOL 1400 microscope with attached 
AMT digital camera.
RNA preparation and real-time quantitative RT-PCR
Total RNA was isolated from kidneys using a Qiagen RNA extraction kit 
following the manufacturer’s instructions. After quantification, RNA 
quality was assessed using agarose gels. From isolated RNA, cDNA was 
prepared using reverse transcriptase (Superscript II; Invitrogen). Real-time 
quantitative RT-PCR (TaqMan) was performed using SYBRGreen PCR 
master mix and analyzed with a Light Cycler 480 (Roche). All gene expres-
Figure 7
Role of DCs in CaOx nephropathy. CD45+CD11c+ cells were extracted from C57BL/6 by magnetic beads and sorted by flow cytometry using 
antibodies for the activation markers CD40 and MHC class II. (A) Percentage of cells with the specific markers. (B) CD45+CD11c+ cells were 
examined by scanning EM. DCs from CaOx mice showed marked cell surface disruption compared with the smooth bosselated surface of 
control cells. Scale bars: 2.5 μm. (C) CaOx nephropathy was induced in mice depleted of DCs (pretreated with clodronate liposomes) and 
compared with that in mice treated with control liposomes. (D) The same analyses were performed in CD11c DTRg mice in which CD11c+ 
cells were depleted by diphtheria toxin (DT) injection. Data are means ± SEM from 5–6 mice per group. *P < 0.05, **P < 0.01, ***P < 0.001.
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Results were expressed as percent of positive control. For ATP release, 
the system bioluminescence detection kit for ATP measurement was 
used (Promega), following the manufacturer’s instructions.
Coculture studies
Briefly, TECs and BMDCs were generated as described above. TECs were 
treated with or without 100 μg/ml CaOx for 18 hours, after which the 
supernatants were treated with 1 U/ml apyrase (Sigma-Aldrich). Next, 
LPS-primed (1 μg/ml) or unprimed BMDCs were cocultured with the 
TECs at a 4:1 ratio in RPMI 1640 (Gibco, Invitrogen) supplemented with 
10% FBS. After 24 hours of coculture, the supernatants were collected, 
centrifuged, and analyzed for IL-1β concentration by ELISA (BD Biosci-
ences — Pharmingen).
Immunoblots
Upon completion of the 6-hour stimulation experiment, supernatants and 
cells were collected. Supernatants were concentrated using Amicon Ultra 
centrifugal filters (Millipore Billerica) and resolved on 15% SDS polyacryl-
isolated from the kidneys and grown on type IV collagen–coated tis-
sue culture plates (Sigma-Aldrich). Primary renal ECs and MCs were 
isolated as described previously (26). The isolated primary cells were 
confirmed under light microscope and further characterized by FACS, 
immunostaining, Western blot, and RT-PCR. Cells were grown to 
confluency before use. 1 × 105 cells per well were used. Primary TECs 
were maintained in DMEM/F12 (Sigma-Aldrich) containing 10% FCS 
(Sigma-Aldrich), 1% penicillin-streptomycin (Sigma-Aldrich), 125 ng/
ml prostaglandin E1 (Calbiochem), 25 ng/ml EGF (Sigma-Aldrich), 
1.8 μg/ml l-thyroxine (Sigma-Aldrich), 3.38 ng/ml hydrocortisone 
(Sigma-Aldrich), and 2.5 mg/ml insulin–transferrin–sodium selenite 
supplement (I-T-SS; Sigma-Aldrich). Primary endothelia and MCs 
were maintained in DMEM (Gibco, Invitrogen) plus 10% FCS and 
1% penicillin-streptomycin, and primary renal DCs were maintained 
in RPMI (Gibco, Invitrogen) and used immediately. All cells were cul-
tured in an incubator at 37°C, 5% CO2. Supernatants were analyzed for 
LDH release using the CytoTox 96 Non-Radioactive Cytotoxicity Assay 
Kit (Promega) to evaluate cell death, measuring LDH after 18 hours. 
Figure 8
Apyrase and anakinra treatment in 
CaOx nephropathy in C57BL/6 mice. 
Oxalate nephropathy was induced in 
C57BL/6 mice treated with or with-
out apyrase (A) and anakinra (B), 
and oxalate deposition was quanti-
fied using Pizzolato stains. Plasma 
creatinine levels were determined as 
described in Methods. Tubular injury 
score was determined by semiquan-
titative scoring of PAS sections, and 
renal neutrophil counts were deter-
mined by immunostaining and quan-
tified per hpf. Original magnification, 
×100. Data are means ± SEM from 5–6 
mice per group. *P < 0.05, **P < 0.01, 
***P < 0.001. ND, not done.
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